Medical and Pharmaceutical Neurogene patient dies in drug trial, stock surges after FDA says ‘use lower dose’ This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401 Rowan DunneNovember 22, 2024
Health & Wellness EverythingALS and NeuroSense take aim at Lou Gehrig’s disease ALS affects up to 30,000 people in the United States with 5,000 new cases every year, according to John Hopkins Medicine. Joseph MortonAugust 2, 2022